Delivery Order SPE2DX16D9411-SPE2DX24FEPAD

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $10K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order with a ceiling value of $12,680.98. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to provide a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $12,934.05, is for the delivery of a range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $12,934.05. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group specializes in supplying a wide range of branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $1,278.20. The contract was awarded by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. The contract is part of a larger indefinite...
This firm fixed-price delivery order contract, valued at $11,006.95, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) Medical Supply Chain division. The contract, which runs through July 2, 2024, is for the provision of a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order contract with a ceiling value of $49,897.20. The contract is awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, which falls under the Department of Defense. The contract covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
  • SPE2DX16D9411
    Indefinite Delivery Contract
  • SPE2DX16D9411-SPE2DX24FEPAD
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $10,093.50. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These supplies are intended to fulfill the recurring medical needs of various Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive array of pharmaceutical items to support the diverse medical requirements of military personnel and their dependents across DoD healthcare facilities.

Generated 11/26/24, 9:06 AM